End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 CNY | +6.99% | +8.40% | +17.82% |
Apr. 24 | Runben Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.35B 186M | Sales 2025 * | 1.72B 237M | Capitalization | 8.67B 1.2B |
---|---|---|---|---|---|
Net income 2024 * | 287M 39.63M | Net income 2025 * | 360M 49.71M | EV / Sales 2024 * | 6.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.04 x |
P/E ratio 2024 * |
30.2
x | P/E ratio 2025 * |
24.1
x | Employees | 917 |
Yield 2024 * |
0.9% | Yield 2025 * |
1.12% | Free-Float | 14.99% |
1 day | +6.99% | ||
1 week | +8.40% | ||
1 month | +14.98% | ||
3 months | +26.45% | ||
6 months | +25.04% | ||
Current year | +17.82% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.42 | +6.99% | 3,256,610 |
24-05-30 | 20.02 | -0.69% | 1,493,783 |
24-05-29 | 20.16 | +0.15% | 1,292,247 |
24-05-28 | 20.13 | +1.51% | 1,969,044 |
24-05-27 | 19.83 | +0.35% | 1,156,603 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603193 Stock